• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Dramatic improvement in hereditary hemorrhagic telangiectasia after treatment with the vascular endothelial growth factor (VEGF) antagonist bevacizumab.

作者信息

Flieger Dimitri, Hainke Sabine, Fischbach Wolfgang

出版信息

Ann Hematol. 2006 Sep;85(9):631-2. doi: 10.1007/s00277-006-0147-8. Epub 2006 Jun 29.

DOI:10.1007/s00277-006-0147-8
PMID:16807748
Abstract
摘要

相似文献

1
Dramatic improvement in hereditary hemorrhagic telangiectasia after treatment with the vascular endothelial growth factor (VEGF) antagonist bevacizumab.
Ann Hematol. 2006 Sep;85(9):631-2. doi: 10.1007/s00277-006-0147-8. Epub 2006 Jun 29.
2
Hereditary hemorrhagic telangiectasia/avastin.遗传性出血性毛细血管扩张症/阿瓦斯汀。
Laryngoscope. 2010 Feb;120(2):432-5. doi: 10.1002/lary.20757.
3
In reference to hereditary hemorrhagic telangiectasia/avastin.
Laryngoscope. 2010 Oct;120(10):2134. doi: 10.1002/lary.21035.
4
Intravenous and topical intranasal bevacizumab (Avastin) in hereditary hemorrhagic telangiectasia.遗传性出血性毛细血管扩张症的静脉和鼻内局部应用贝伐单抗（阿瓦斯汀）。
Am J Otolaryngol. 2012 May-Jun;33(3):349-51. doi: 10.1016/j.amjoto.2011.07.012. Epub 2011 Sep 13.
5
Bevacizumab treatment in multifocal lymphangioendotheliomatosis with thrombocytopenia.贝伐单抗治疗伴血小板减少的多灶性淋巴管内皮瘤病。
Pediatr Blood Cancer. 2009 Apr;52(4):534-6. doi: 10.1002/pbc.21860.
6
[A case with liver resection of metastasis from rectal cancer after bevacizumab treatment].
Gan To Kagaku Ryoho. 2010 Nov;37(12):2517-9.
7
More on bevacizumab in hereditary hemorrhagic telangiectasia.关于贝伐单抗在遗传性出血性毛细血管扩张症中的更多信息。
N Engl J Med. 2009 Aug 27;361(9):931; author reply 931-2. doi: 10.1056/NEJMc091271.
8
More on bevacizumab in hereditary hemorrhagic telangiectasia.贝伐单抗治疗遗传性出血性毛细血管扩张症的更多研究
N Engl J Med. 2009 Aug 27;361(9):931; author reply 931-2.
9
Bevacizumab as rescue treatment for severe recurrent gastrointestinal bleeding in hereditary hemorrhagic telangiectasia.贝伐珠单抗作为遗传性出血性毛细血管扩张症重度复发性胃肠道出血的挽救性治疗。
J Clin Gastroenterol. 2013 Mar;47(3):256-7. doi: 10.1097/MCG.0b013e3182688d49.
10
Low dose of bevacizumab is safe and effective in preventing bleeding episodes in hereditary hemorrhagic telangiectasia.低剂量贝伐单抗在预防遗传性出血性毛细血管扩张症出血发作方面安全有效。
Am J Gastroenterol. 2011 Dec;106(12):2204-6. doi: 10.1038/ajg.2011.287.

引用本文的文献

1
Extracranial arteriovenous malformations: towards etiology-based therapeutic management.颅外动静脉畸形：迈向基于病因的治疗管理
J Clin Invest. 2025 Mar 17;135(6):e172837. doi: 10.1172/JCI172837.
2
Efficacy of bevacizumab in hereditary hemorrhagic telangiectasia: a systematic review and network meta-analysis.贝伐单抗治疗遗传性出血性毛细血管扩张症的疗效：一项系统评价和网状Meta分析
Eur Arch Otorhinolaryngol. 2025 Feb 1. doi: 10.1007/s00405-024-09177-9.
3
Defining the Role of Oral Pathway Inhibitors as Targeted Therapeutics in Arteriovenous Malformation Care.
确定口服通路抑制剂在动静脉畸形治疗中作为靶向治疗药物的作用。
Biomedicines. 2024 Jun 11;12(6):1289. doi: 10.3390/biomedicines12061289.
4
Congenital Vascular and Lymphatic Diseases.先天性血管和淋巴管疾病。
Circ Res. 2024 Jun 21;135(1):159-173. doi: 10.1161/CIRCRESAHA.124.323181. Epub 2024 Jun 20.
5
Hereditary hemorrhagic telangiectasia: from signaling insights to therapeutic advances.遗传性出血性毛细血管扩张症：从信号通路研究到治疗进展。
J Clin Invest. 2024 Feb 15;134(4):e176379. doi: 10.1172/JCI176379.
6
Meta-analysis of efficacy and safety of bevacizumab in the treatment of hereditary hemorrhagic telangiectasia epistaxis.贝伐单抗治疗遗传性出血性毛细血管扩张症鼻出血疗效及安全性的荟萃分析。
Front Pharmacol. 2023 Dec 12;14:1089847. doi: 10.3389/fphar.2023.1089847. eCollection 2023.
7
Induced Endothelial Cell Cycle Arrest Prevents Arteriovenous Malformations in Hereditary Hemorrhagic Telangiectasia.诱导内皮细胞周期停滞可预防遗传性出血性毛细血管扩张症中的动静脉畸形。
Circulation. 2024 Mar 19;149(12):944-962. doi: 10.1161/CIRCULATIONAHA.122.062952. Epub 2023 Dec 21.
8
Late-Onset Ovarian Bleeding After Transvaginal Oocyte Retrieval in a Patient With Suspected Hereditary Hemorrhagic Telangiectasia.疑似遗传性出血性毛细血管扩张症患者经阴道取卵术后迟发性卵巢出血
Cureus. 2023 Sep 21;15(9):e45657. doi: 10.7759/cureus.45657. eCollection 2023 Sep.
9
Randomized, double-blind, placebo-controlled, crossover trial of oral doxycycline for epistaxis in hereditary hemorrhagic telangiectasia.随机、双盲、安慰剂对照、交叉试验口服多西环素治疗遗传性出血性毛细血管扩张症鼻出血。
Orphanet J Rare Dis. 2022 Nov 7;17(1):405. doi: 10.1186/s13023-022-02539-8.
10
Hereditary Hemorrhagic Telangiectasia Associating Neuropsychiatric Manifestations with a Significant Impact on Disease Management-Case Report and Literature Review.遗传性出血性毛细血管扩张症合并神经精神表现对疾病管理有重大影响——病例报告及文献综述
Life (Basel). 2022 Jul 15;12(7):1059. doi: 10.3390/life12071059.